At-risk patient and healthcare provider perspectives on clinical trial participation for ductal carcinoma in situ.

被引：0
|
作者：
Adams, Elizabeth
Kulkarni, Swati
Zheng, Veronica
Warwar, Samantha Ahsan
Brown, Denisha
Schulte, Lauren
Cooper, Robin
Labomascus, Bazil
Bhavsar, Erica B.
机构：
[1] Northwestern Univ Feinberg Sch Med, Chicago, IL USA
[2] Northwestern Mem Hosp, Dept Surg, Chicago, IL USA
[3] Northwestern Univ, Chicago, IL USA
[4] Robin Cooper Res Grp Inc, Winter Garden, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10539
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ The COMET Randomized Clinical Trial
    Hwang, E. Shelley
    Hyslop, Terry
    Lynch, Thomas
    Ryser, Marc D.
    Weiss, Anna
    Wolf, Anna
    Norris, Kelsey
    Witten, Meredith
    Grimm, Lars
    Schnitt, Stuart
    Badve, Sunil
    Factor, Rachel
    Frank, Elizabeth
    Collyar, Deborah
    Basila, Desiree
    Pinto, Donna
    Watson, Mark A.
    West, Robert
    Davies, Louise
    Donovan, Jenny L.
    Shimada, Ayako
    Li, Yutong
    Li, Yan
    Bennett, Antonia V.
    Rosenberg, Shoshana
    Marks, Jeffrey
    Winer, Eric
    Boisvert, Marc
    Giuliano, Armando
    Larson, Kelsey E.
    Yost, Kathleen
    Mcauliffe, Priscilla F.
    Krie, Amy
    Tamirisa, Nina
    Carey, Lisa A.
    Thompson, Alastair M.
    Partridge, Ann H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (11): : 972 - 980
  • [22] Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ (DCIS) Patient Population at Low-risk of Upgrade to Invasive Carcinoma?
    Pilewskie, M.
    Stempel, M.
    Rosenfeld, H.
    Eaton, A.
    Van Zee, K. J.
    Morrow, M.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S25 - S26
  • [23] Novel clinical trial designs for treatment of ductal carcinoma in situ of the breast with trastuzumab (Herceptin)
    Gonzalez, Ricardo J.
    Buzdar, Aman U.
    Symmans, W. Fraser
    Yen, Tina W.
    Broglio, Kristine R.
    Lucci, Anthony
    Esteva, Francisco J.
    Yin, Guosheng
    Kuerer, Henry M.
    BREAST JOURNAL, 2007, 13 (01): : 72 - 75
  • [24] Patient Selection for Ductal Carcinoma In Situ Observation Trials: Are the Lesions Truly Low Risk?
    Patel, Gitanjali V.
    Van Sant, Eduardo Pascual
    Taback, Bret
    Ha, Richard
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2018, 211 (03) : 712 - 713
  • [25] Clinical characteristics and management of a Greek female patient cohort with breast ductal carcinoma in situ
    Panousis, Dimitrios
    Kontogianni, Panagiota
    Ntasiou, Panagiota
    Paraskevakou, Georgia
    Grosomanidis, Dimitrios
    Chatzopoulos, Konstantinos
    Charitidou, Efstratia
    Xepapadakis, Grigoris
    JOURNAL OF BUON, 2016, 21 (04): : 809 - 817
  • [26] Patient perspectives on clinical trial participation: A pilot survey of gynecologic cancer survivors
    Ellis, A.
    Scroggins, M. J.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 250 - 251
  • [27] Understanding Patient Perspectives on Window of Opportunity Clinical Trial Participation in Breast Cancer
    Ozuna, Vanessa Lopez
    Pond, Gregory R.
    Bartlett, John Ms
    Radvanyi, Lazlo
    Spears, Melanie
    Petrocelli, Teresa
    Gordon, Carol
    Rose, Rebecca J.
    Arnaout, Angel
    CANCER RESEARCH, 2023, 83 (05)
  • [28] Patient, Provider, and Advocate Perspectives on Factors that Impact Participation of Black Women in Breast Cancer Clinical Trials
    Carnahan, Leslie R.
    Cohn, Eliza B.
    Mersha, Tigist
    Hippalgaonkar, Neha
    Nguyen, Ryan
    Salum, Kauthar
    Waite, Ana Williams
    Sandoval, Christen
    Coleman, Lolita
    Brent, Beulah
    Thomas, Paris
    Khosla, Paramjeet
    Hoskins, Kent F.
    Henderson, Vida
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (09)
  • [29] Canadian perspectives in multiple myeloma on the use of steroids in clinical practice based on patient and healthcare provider interviews
    McKenzie, Farah
    Gazze, Gabriel
    Hewitt, Joanne
    Kolm, Kari
    Pollock, Debra
    Rowland, Suzanne
    Crosbie, Tina
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [30] Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS)
    Waernberg, Fredrik
    Karlsson, Per
    Holmberg, Erik
    Sandelin, Kerstin
    Whitworth, Pat W.
    Savala, Jess
    Barry, Todd
    Leesman, Glen
    Linke, Steven P.
    Shivers, Steven C.
    Vicini, Frank
    Shah, Chirag
    Weinmann, Sheila
    Mann, Gregory Bruce
    Bremer, Troy
    CANCERS, 2021, 13 (23)
12345